Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
3.920
-0.030 (-0.76%)
At close: Sep 15, 2025, 4:00 PM EDT
3.920
0.00 (0.01%)
After-hours: Sep 15, 2025, 5:15 PM EDT

Genelux Statistics

Total Valuation

Genelux has a market cap or net worth of $146.37 million. The enterprise value is $117.31 million.

Market Cap146.37M
Enterprise Value 117.31M

Important Dates

The next estimated earnings date is Thursday, November 13, 2025, after market close.

Earnings Date Nov 13, 2025
Ex-Dividend Date n/a

Share Statistics

Genelux has 37.34 million shares outstanding. The number of shares has increased by 29.38% in one year.

Current Share Class 37.34M
Shares Outstanding 37.34M
Shares Change (YoY) +29.38%
Shares Change (QoQ) +8.65%
Owned by Insiders (%) 10.58%
Owned by Institutions (%) 19.88%
Float 33.39M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 6.17
P/TBV Ratio 6.01
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.18, with a Debt / Equity ratio of 0.07.

Current Ratio 4.18
Quick Ratio 4.00
Debt / Equity 0.07
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -98.72% and return on invested capital (ROIC) is -61.65%.

Return on Equity (ROE) -98.72%
Return on Assets (ROA) -52.14%
Return on Invested Capital (ROIC) -61.65%
Return on Capital Employed (ROCE) -127.86%
Revenue Per Employee n/a
Profits Per Employee -$1.27M
Employee Count24
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +60.66% in the last 52 weeks. The beta is -0.35, so Genelux's price volatility has been lower than the market average.

Beta (5Y) -0.35
52-Week Price Change +60.66%
50-Day Moving Average 3.46
200-Day Moving Average 3.17
Relative Strength Index (RSI) 62.72
Average Volume (20 Days) 137,366

Short Selling Information

The latest short interest is 2.12 million, so 5.67% of the outstanding shares have been sold short.

Short Interest 2.12M
Short Previous Month 2.22M
Short % of Shares Out 5.67%
Short % of Float 6.34%
Short Ratio (days to cover) 22.03

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -32.30M
Pretax Income -25.78M
Net Income -30.39M
EBITDA -32.06M
EBIT -32.30M
Earnings Per Share (EPS) -$0.86
Full Income Statement

Balance Sheet

The company has $27.97 million in cash and $1.71 million in debt, giving a net cash position of $26.27 million or $0.70 per share.

Cash & Cash Equivalents 27.97M
Total Debt 1.71M
Net Cash 26.27M
Net Cash Per Share $0.70
Equity (Book Value) 23.90M
Book Value Per Share 0.64
Working Capital 22.25M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$22.54 million and capital expenditures -$268,000, giving a free cash flow of -$22.81 million.

Operating Cash Flow -22.54M
Capital Expenditures -268,000
Free Cash Flow -22.81M
FCF Per Share -$0.61
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Genelux does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -29.38%
Shareholder Yield -29.38%
Earnings Yield -21.17%
FCF Yield -15.89%

Analyst Forecast

The average price target for Genelux is $17.75, which is 352.81% higher than the current price. The consensus rating is "Strong Buy".

Price Target $17.75
Price Target Difference 352.81%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) 646.67%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Genelux has an Altman Z-Score of -7.01 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -7.01
Piotroski F-Score 1